Slattery M L, Edwards S L, Ma K N, Friedman G D
University of Utah, School of Medicine, Salt Lake City, USA.
Cancer Causes Control. 2000 Jul;11(6):555-63. doi: 10.1023/a:1008924115604.
Sigmoidoscopy screening and fecal occult blood (FOB) tests have been demonstrated as effective ways to reduce mortality from colorectal cancer. However, most studies of colorectal cancer screening and cancer mortality have not taken into consideration lifestyle factors that could account for the observed associations. The purpose of this study was to determine the association between screening and incidence of colon cancer, taking into consideration important lifestyle factors.
We estimated the association between screening and colon cancer after taking into consideration health and lifestyle factors using data obtained as part of population-based case-control study of incident colon cancers.
Sigmoidoscopy screening, especially as part of a checkup, was protective against incident colon cancer in both men (OR 0.56, 95% CI 0.44-0.77) and women (OR 0.53, 95% CI 0.33-0.77) after adjusting for other risk factors for colon cancer. For men, associations were stronger for distal tumors (OR 0.48, 95% CI 0.31-0.71) than for proximal tumors (OR 0.67, 95% CI 0.45-1.11). We did not observe significant associations between FOB test and colon cancer. Differences in characteristics between those who were screened and not screened were also observed. Men were more likely to report having a sigmoidoscopy as part of a checkup than were women, as were people with higher levels of education. People who reported having a sigmoidoscopy as part of a checkup also reported eating diets lower in fat and higher in fiber, folate, and vegetables. Men were more likely to report higher levels of physical activity, and women were more likely to report taking hormone replacement therapy (HRT) if they also reported a sigmoidoscopy. Both men and women who reported a sigmoidoscopy for screening purposes were more likely to have a family history of colorectal cancer.
These data provide additional support for the benefits of having a screening sigmoidoscopy. The associations between screening sigmoidoscopy and colon cancer do not appear to be the result of lifestyle factors.
乙状结肠镜检查筛查和粪便潜血(FOB)检测已被证明是降低结直肠癌死亡率的有效方法。然而,大多数关于结直肠癌筛查和癌症死亡率的研究并未考虑可能解释所观察到的关联的生活方式因素。本研究的目的是在考虑重要生活方式因素的情况下,确定筛查与结肠癌发病率之间的关联。
我们利用作为基于人群的新发结肠癌病例对照研究的一部分所获得的数据,在考虑健康和生活方式因素后,估计筛查与结肠癌之间的关联。
在调整其他结肠癌风险因素后,乙状结肠镜检查筛查,尤其是作为体检的一部分,对男性(OR 0.56,95% CI 0.44 - 0.77)和女性(OR 0.53,95% CI 0.33 - 0.77)的新发结肠癌具有保护作用。对于男性,远端肿瘤的关联(OR 0.48,95% CI 0.31 - 0.71)比近端肿瘤更强(OR 0.67,95% CI 0.45 - 1.11)。我们未观察到FOB检测与结肠癌之间存在显著关联。还观察到了接受筛查和未接受筛查者在特征上的差异。男性比女性更有可能报告将乙状结肠镜检查作为体检的一部分,受过高等教育的人也是如此。报告将乙状结肠镜检查作为体检一部分的人还报告其饮食中脂肪含量较低,而纤维、叶酸和蔬菜含量较高。男性更有可能报告有较高水平的身体活动,而女性如果报告进行了乙状结肠镜检查,也更有可能报告接受激素替代疗法(HRT)。报告为筛查目的而进行乙状结肠镜检查的男性和女性都更有可能有结直肠癌家族史。
这些数据为进行乙状结肠镜检查筛查的益处提供了更多支持。乙状结肠镜检查筛查与结肠癌之间的关联似乎并非生活方式因素所致。